Keros' cash and cash equivalents as of March 31, 2025 was $720.5 million compared to $559.9 million as of December 31, 2024.

Webcasts will be available on the Caribou website for at least 30 days after the event. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing ...

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Tuesday reported a loss of $96.1 million in its first quarter. The Emeryville, California-based company said it ...

Phathom Pharmaceuticals, Inc.’s PHAT share price has dipped by 5.62%, which has investors questioning if this is right time to buy.

ORIC Pharmaceuticals, Inc.’s ORIC share price has dipped by 7.54%, which has investors questioning if this is right time to buy.